Organogenesis Holdings Stock Price To Book
| ORGO Stock | USD 2.74 0.11 3.86% |
Organogenesis Holdings fundamentals help investors to digest information that contributes to Organogenesis Holdings' financial success or failures. It also enables traders to predict the movement of Organogenesis Stock. The fundamental analysis module provides a way to measure Organogenesis Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Organogenesis Holdings stock.
As of the 20th of May 2024, Price To Book Ratio is likely to drop to 1.83. Organogenesis | Price To Book |
Organogenesis Holdings Company Price To Book Analysis
Organogenesis Holdings' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Organogenesis Holdings Price To Book | 1.37 X |
Most of Organogenesis Holdings' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Organogenesis Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Organogenesis Price To Book Driver Correlations
Understanding the fundamental principles of building solid financial models for Organogenesis Holdings is extremely important. It helps to project a fair market value of Organogenesis Stock properly, considering its historical fundamentals such as Price To Book. Since Organogenesis Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Organogenesis Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Organogenesis Holdings' interrelated accounts and indicators.
Click cells to compare fundamentals
Organogenesis Price To Book Historical Pattern
Today, most investors in Organogenesis Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Organogenesis Holdings' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to book growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Organogenesis Holdings price to book as a starting point in their analysis.
Organogenesis Holdings Price To Book |
| Timeline |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Organogenesis Book Value Per Share
Book Value Per Share |
|
Based on the latest financial disclosure, Organogenesis Holdings has a Price To Book of 1.3733 times. This is 94.65% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The price to book for all United States stocks is 85.56% higher than that of the company.
Organogenesis Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Organogenesis Holdings' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Organogenesis Holdings could also be used in its relative valuation, which is a method of valuing Organogenesis Holdings by comparing valuation metrics of similar companies.Organogenesis Holdings is currently under evaluation in price to book category among related companies.
Organogenesis Holdings Current Valuation Drivers
We derive many important indicators used in calculating different scores of Organogenesis Holdings from analyzing Organogenesis Holdings' financial statements. These drivers represent accounts that assess Organogenesis Holdings' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Organogenesis Holdings' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 446.6M | 811.3M | 1.2B | 349.9M | 536.7M | 726.0M | |
| Enterprise Value | 487.0M | 811.6M | 1.2B | 371.2M | 551.7M | 744.2M |
Organogenesis Holdings ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Organogenesis Holdings' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Organogenesis Holdings' managers, analysts, and investors.Environmental | Governance | Social |
Organogenesis Fundamentals
| Return On Equity | 0.0215 | ||||
| Return On Asset | 0.0201 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 393.29 M | ||||
| Shares Outstanding | 132.57 M | ||||
| Shares Owned By Insiders | 32.87 % | ||||
| Shares Owned By Institutions | 43.71 % | ||||
| Number Of Shares Shorted | 9.74 M | ||||
| Price To Earning | 17.12 X | ||||
| Price To Book | 1.37 X | ||||
| Price To Sales | 0.88 X | ||||
| Revenue | 433.14 M | ||||
| Gross Profit | 345.87 M | ||||
| EBITDA | 39.77 M | ||||
| Net Income | 4.95 M | ||||
| Cash And Equivalents | 113.24 M | ||||
| Cash Per Share | 0.87 X | ||||
| Total Debt | 119.35 M | ||||
| Debt To Equity | 0.52 % | ||||
| Current Ratio | 2.62 X | ||||
| Book Value Per Share | 2.10 X | ||||
| Cash Flow From Operations | 30.92 M | ||||
| Short Ratio | 8.01 X | ||||
| Earnings Per Share | 0.04 X | ||||
| Price To Earnings To Growth | 6.15 X | ||||
| Target Price | 4.67 | ||||
| Number Of Employees | 862 | ||||
| Beta | 1.6 | ||||
| Market Capitalization | 363.25 M | ||||
| Total Asset | 460.02 M | ||||
| Retained Earnings | (40.97 M) | ||||
| Working Capital | 144.53 M | ||||
| Current Asset | 24.47 M | ||||
| Current Liabilities | 23.22 M | ||||
| Net Asset | 460.02 M |
About Organogenesis Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Organogenesis Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Organogenesis Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Organogenesis Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Organogenesis Holdings Piotroski F Score and Organogenesis Holdings Altman Z Score analysis. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.Note that the Organogenesis Holdings information on this page should be used as a complementary analysis to other Organogenesis Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Organogenesis Stock analysis
When running Organogenesis Holdings' price analysis, check to measure Organogenesis Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organogenesis Holdings is operating at the current time. Most of Organogenesis Holdings' value examination focuses on studying past and present price action to predict the probability of Organogenesis Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organogenesis Holdings' price. Additionally, you may evaluate how the addition of Organogenesis Holdings to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Organogenesis Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 11.307 | Earnings Share 0.04 | Revenue Per Share 3.313 | Quarterly Revenue Growth 0.022 | Return On Assets 0.0201 |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.